Deccan Health Care profit falls 40% despite sales growth
Key highlights
- Deccan Health Care’s consolidated first-half profit after tax fell 40% to Rs 68.95 lakh.
- Deccan Health Care’s revenue from operations rose 14% to Rs 49.52 crore in the half year ended 30 September 2026.
- Deccan Health Care’s material consumption increased 24% to Rs 39.32 crore from Rs 31.68 crore.
- Deccan Health Care used Rs 5.93 crore in operating activities, compared with Rs 3.77 crore a year earlier.
powered by IRIS

Deccan Health Care Limited reported consolidated profit after tax of Rs 68.95 lakh for the half year ended 30 September 2026, 40% below Rs 115.11 lakh a year earlier, even as revenue from operations rose 14% to Rs 49.52 crore. Higher material consumption, employee costs and finance costs accompanied the increase in sales.
Know Deccan Health Care inside out
Results, valuation, peers and who's buying, in one view.
What were Deccan Health Care’s first-half results?
Deccan Health Care recorded revenue from operations of Rs 49.52 crore in the half year ended 30 September 2026, compared with Rs 43.53 crore in the corresponding 2025 half year. The Rs 5.99 crore increase lifted reported revenue by about 14%, while other income rose to Rs 3.73 lakh from Rs 75,000.
Deccan Health Care’s total income was Rs 49.56 crore for the latest half year, against Rs 43.54 crore a year earlier. Profit before tax declined to Rs 91.99 lakh from Rs 155.93 lakh, a reduction of Rs 63.94 lakh despite the higher revenue base.
Deccan Health Care paid total tax of Rs 23.04 lakh in the latest period, comprising current tax of Rs 30.54 lakh and a deferred-tax credit of Rs 7.50 lakh. In the comparable half year, total tax expense was Rs 40.82 lakh, including current tax of Rs 47.75 lakh and a deferred-tax credit of Rs 6.93 lakh.
Deccan Health Care reported total comprehensive income of Rs 68.39 lakh, down from Rs 122.72 lakh in the prior-year half. The latest figure included an other comprehensive loss of Rs 56,000, whereas the corresponding period included other comprehensive income of Rs 7.61 lakh; basic and diluted earnings per share were Rs 0.28, against Rs 0.47.
Why did Deccan Health Care’s profit decline despite higher revenue?
Deccan Health Care’s material consumption rose faster than revenue, increasing 24% to Rs 39.32 crore from Rs 31.68 crore. The Rs 7.64 crore increase in material cost exceeded the Rs 5.99 crore increase in revenue from operations, which helps explain why profit before tax fell by Rs 63.94 lakh.
Deccan Health Care also reported employee benefit expense of Rs 2.62 crore, compared with Rs 2.35 crore in the previous-year half. Finance costs increased to Rs 31.69 lakh from Rs 18.15 lakh, while depreciation and amortisation rose to Rs 77.75 lakh from Rs 73.27 lakh.
Deccan Health Care’s other expenses declined to Rs 9.16 crore from Rs 10.04 crore, partly offsetting the increases in material, employee and finance costs. Changes in inventories of finished goods, work in progress and stock-in-trade were negative Rs 3.55 crore, compared with negative Rs 1.51 crore in the earlier half year.
Deccan Health Care did not provide a business-level explanation for these movements because it stated that segment reporting was not applicable. The filing therefore does not identify the product lines, customer categories or operating units behind the Rs 49.52 crore of first-half revenue or the Rs 39.32 crore of material consumption.
Got a follow-up? Ask IRIS
How did Deccan Health Care perform in the September 2026 quarter?
Deccan Health Care reported revenue from operations of Rs 27.46 crore in the quarter ended 30 September 2026, compared with Rs 22.06 crore in the quarter ended 30 June 2026 and Rs 21.39 crore in the quarter ended 30 September 2025. Revenue was therefore higher by Rs 5.39 crore sequentially and by Rs 6.06 crore from the year-earlier quarter.
Deccan Health Care’s quarterly profit after tax was Rs 39.84 lakh, compared with Rs 29.11 lakh in the June 2026 quarter. Profit before tax increased to Rs 53.14 lakh from Rs 38.85 lakh sequentially, while the tax expense for the September 2026 quarter was Rs 13.30 lakh.
Deccan Health Care’s September 2026 quarter had profit before tax of Rs 53.14 lakh, below Rs 122.54 lakh in the September 2025 quarter, although quarterly revenue increased year on year. The company said the September 2026 quarter figures were balancing figures between the half-year results and the first-quarter figures ended 30 June 2026, which were subject to limited review.
What changed in Deccan Health Care’s balance sheet and cash flow?
Deccan Health Care’s consolidated total assets stood at Rs 156.41 crore at 30 September 2026, compared with Rs 148.90 crore at 31 March 2026. Current assets increased to Rs 137.93 crore from Rs 129.73 crore, while non-current assets decreased to Rs 18.48 crore from Rs 19.17 crore.
Deccan Health Care’s inventories fell to Rs 37.44 crore at 30 September from Rs 46.96 crore at the March year-end. Trade receivables rose to Rs 17.37 crore from Rs 16.98 crore, cash and cash equivalents increased to Rs 2.13 crore from Rs 1.64 crore, and other current assets rose to Rs 80.17 crore from Rs 63.32 crore.
Deccan Health Care’s total equity was Rs 110.95 crore, compared with Rs 110.26 crore at 31 March 2026. Total liabilities increased to Rs 45.46 crore from Rs 38.64 crore, with short-term borrowings rising to Rs 8.19 crore from Rs 1.25 crore and current tax liabilities increasing to Rs 2.61 crore from Rs 1.28 crore.
Deccan Health Care used Rs 5.93 crore of cash in operating activities during the six months, compared with Rs 3.77 crore used in the prior-year period. The latest operating cash movement included a Rs 16.84 crore increase in other current assets, partly offset by a Rs 9.52 crore reduction in inventories.
Deccan Health Care used Rs 1.96 lakh in investing activities, compared with Rs 5.55 lakh a year earlier, including Rs 5.69 lakh spent on fixed assets. Its subsidiary, Beyoungstore Private Limited, reported half-year revenue of Rs 4.96 crore and profit after tax of Rs 7.34 lakh; the statutory auditor said it had not reviewed the subsidiary’s interim financial results and relied on the review report furnished by management.
Conclusion
Deccan Health Care’s first-half results show that the 14% increase in revenue did not translate into higher earnings. Material consumption rose by Rs 7.64 crore, exceeding the Rs 5.99 crore gain in revenue, while employee costs and finance costs also increased, resulting in a 40% decline in profit after tax to Rs 68.95 lakh.
The next results will show whether the Rs 16.84 crore increase in other current assets and Rs 5.93 crore operating cash outflow reverse or persist. The filing also leaves unresolved the business-level sources of the cost changes because Deccan Health Care does not report segments, while the subsidiary’s Rs 4.96 crore half-year revenue was not independently reviewed by the statutory auditor.


